Canada was very much interested in being part of global efforts to develop a vaccine. At the time that started, one of the deficiencies, or one of the challenges, was having trial-lot production facilities for clinical trials. That's why, as part of Canada's CHVI strategy, that was one of the areas of focus. In the subsequent time, that has now been addressed, so those resources are better used elsewhere.
On March 18th, 2010. See this statement in context.